Viruses May Trigger Lung Cancer Development
Viruses causing measles and human papillomavirus may create auspicious conditions for lung cancer to develop.
|
Immunotherapy Shows Promise For Lung Cancer Treatment
Long-term clinical trial results that were presented last Friday at the 1st European Lung Cancer Conference demonstrate that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery to the same extent as chemotherapy.
|
HPV Viruses May Play a Role In Causing Lung Cancer
Papers presented at the 1st European Lung Cancer Conference demonstrate that common viruses such as HPV may play a role in the development of lung cancer.
|
Inflammation Plays Role In Determining Lung Cancer
Findings support the role of inflammation in determining lung cancer risk, particularly among African-American women.
|
ONCONASE Promising As Radiation Sensitizer For Lung Cancer Treatment
Alfacell's ONCONASE (ranpirnase) could be a promising radiation sensitizer for lung cancer treatment.
|
Genetic Variant Linked To Nicotine Addiction, Lung Cancer
Scientists have identified a genetic variant that not only makes smokers more susceptible to nicotine addiction but also increases their risk of developing two smoking-related diseases, lung cancer and peripheral arterial disease.
|
Research Finds Lung Cancer Genes
Researchers say the finding of lung cancer genes is an important discovery because it can provide ways to prevent and offer treatment for lung cancer and explain why some smokers get the disease and other don't and how come people who never smoke can get lung cancer.
|
CyberKnife Radiosurgery Used To Treat Lung Tumors At 90% Of Centers Worldwide
Accuray Incorporated announced that approximately 90 percent of CyberKnife centers worldwide are now treating lung cancer with the CyberKnife Robotic Radiosurgery System.
|
Treatment Gives Lung Cancer Patients With Inoperable Tumors Two Years
Radiofrequency ablation greatly improves survival time from primary or metastatic inoperable lung tumors.
|
Teaching Hospitals Are Safer For Lung Cancer Surgery
Lung cancer surgery risk is lower in teach hospitals. Patients cared for by hospitals with residents in training have a 17 percent less chance of dying after lung cancer surgery compared with patients undergoing surgery at non-teaching hospitals.
|
Asbestos Increase Lung Cancer Risk In Tradesmen
Most tradesmen don't have enough information about risks posed by asbestos, such as lung
|
In Fight Against Lung Cancer Study Offers New Hope
Researchers have discovered biomarkers that predict which patients with advanced non-small-cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex.
|
PET Outperforms CT In Characterization of Benign, Malignant Lung Nodules
Researchers, comparing the accuracy of positron emission tomography (PET) and computed tomography (CT) in the characterization of lung nodules, found that PET was far more reliable in detecting whether or not a nodule was malignant.
|
Cysteine-Rich Protein Prevents Weight Loss In Lung Cancer Patients
Immunotec announced the successful completion of a multi-center randomized, double-blind clinical trial on cancer-related weight loss in lung cancer patients.
|
Transgene's Therapeutic Vaccine Shows Promising Results In Lung Cancer
Transgene announces promising preliminary data from trial evaluating its therapeutic vaccine TG4010 as an adjunct to first line chemotherapy in patients with advanced non-small cell lung cancer.
|
Allos Therapeutics Initiates Study In Patients With Non-small Cell Lung Cancer
Allos Therapeutics initiates patient enrollment in a Phase 2b, randomized, multi-center study comparing PDX and Tarceva in patients with Stage IIIB/IV non-small cell lung cancer.
|
Exelixis Initiates Trial In Patients With Non-Small Cell Lung Cancer
Exelixis has initiated a phase 1/2 trial of XL184 in patients with non-small cell lung cancer who have had progressive disease while on a regimen containing erlotinib.
|
Home Radon Testing Urged To Reduce Lung Cancer Risk
You can't see, smell or taste it, but it may be a problem in your home and is a leading cause of lung cancer deaths. What is this invisible substance? Radon.
|
Marital Status Doesn't Affect Lung Cancer Survival
Contrary to previous studies, married patients with lung cancer do not have longer survival.
|
Scientists Predict Individual Risk Of Lung Cancer
Scientists have developed a model which can predict the risk of any person developing lung cancer within a five-year period.
|
New Therapies Encourage Blood Vessel Formation For Patients With Lung Cancer
Researchers have discovered that microscopic blood vessels in the lungs increase and decrease in the same rhythm as a woman's uterine lining changes.
|
Blood test possibly to detect early signs of lung cancer
Early signs and symptoms of lung cancer may be detected early through a new blood test developed by Duke University Medical Center researchers.
|
High-Tech Battle Against Lung Cancer
Lung cancer is the leading cause of cancer deaths in the U.S. among both men and women.
|
Cleveland Clinic Improves Early-Stage Lung Cancer Detection
Cleveland Clinic and Riverain Medical established the first study in an ongoing program to determine whether chest X-ray CAD can improve practical early detection of lung cancer.
|
Scientists Launch Lung Cancer Early Detection Initiative
Thomas G. Labrecque Foundation has pledged $10 million to the Canary Foundation to support a unique, new collaborative research program to save lives through early detection of lung cancer.
|
Accuray Exceeds 4,000 Lung Cancer Patients Treated With CyberKnife
Accuray Incorporated's CyberKnife Robotic Radiosurgery System has been used to treat more than 4,000 lung cancer patients worldwide.
|
Talk To Your Doctor About Risks Of Lung Cancer
Thanksgiving is a time for counting our blessings but for too many families, the spirit of the season will be diminished by the loss of a loved one to lung cancer.
|
Chemotherapy, Radiation Together Extend Lung Cancer Patients' Lives
Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer.
|
Nonsmokers Get Lung Cancer, Too
About 17 percent of lung cancer cases diagnosed in American females each year occur in women who have never smoked.
|
Radon: Second Leading Cause Of Lung Cancer
Radon is a cancer-causing, radioactive gas that is second only to smoking as a cause of lung cancer.
|
Preventing Lung Scarring May Extend Lives Of Lung Cancer Patients
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients.
|
Genome Study Charts Genetic Landscape Of Lung Cancer
Comprehensive analysis of DNA from human lung tumors uncovers more than 50 common genetic abnormalities, less than half involve known cancer genes.
|
Study Identifies Novel Gene Alterations In Lung Cancer
Systematic effort to map the genomic changes underlying lung cancer has uncovered a critical gene alteration not previously linked to any form of cancer.
|
New Way To Predict Survival In Older Women With Lung Cancer
Researchers have discovered a novel mechanism to predict survival in older women with early stage lung cancer.
|
IDM-2101 Treatment Well Tolerated With Positive Survival Trend In Lung Cancer Patients
IDM Pharma announced updated results from the Phase 2 study of its investigational agent IDM-2101 for lung cancer treatment.
|
Potential Early Warning System For Lung Cancer Identified
New research from The University of Nottingham has pinpointed a potential early warning system for lung cancer.
|
GSK's Hycamtin Approved For Lung Cancer Treatment
GSK receives approval for Hycamtin (topotecan) capsules for the treatment of relapsed small cell lung cancer.
|
Genomic Profiling Of Lung Tumors Helps Doctors Choose Most Effective Treatment
Determining the genetic profile of a particular lung tumor can help clinicians make the crucial decision about which chemotherapy treatment to try first.
|
Genomic profiling of lung tumors helps choosing most effective treatment
Genomic profiling of lung tumors helps doctors choose most effective treatment for lung cancer.
|
Key Correlation Between Lung Cancer Subtype And Treatment Outcomes
Patients with advanced non-small cell lung cancer that are classified as having a non-squamous histology achieve statistically significant higher survival when treated in the second-line setting with ALIMTA.
|
